SCHEMBL30753759

C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@@H](N)CS)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)O

nearest known ligand 0.62

Predicted protein targets (top 15)

	gene	UniProt	supporting neighbours	confidence
▸	NMUR2	Q9GZQ4	6/20	0.62

▸	NMUR1	Q9HB89	6/20	0.62

▸	OPRM1	P35372	4/20	0.59

▸	OPRD1	P41143	4/20	0.59

▸	EPHA2	P29317	2/20	0.58

▸	CXCR4	P61073	3/20	0.55

▸	MAPK8	P45983	1/20	0.55

▸	MAPK9	P45984	1/20	0.55

▸	MAPK10	P53779	1/20	0.55

▸	RAMP3	O60896	1/20	0.54

▸	CALCR	P30988	1/20	0.54

▸	NPY1R	P25929	1/20	0.52

▸	NPY2R	P49146	1/20	0.52

▸	NPY4R	P50391	1/20	0.52

▸	NPY5R	Q15761	1/20	0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL30788350	0.95	NMUR2 (0.58)	NMUR2NMUR1OPRM1OPRD1EPHA2
SCHEMBL30753756	0.93	NMUR2 (0.61)	NMUR2NMUR1OPRM1OPRD1CXCR4
SCHEMBL30753761	0.93	OPRD1 (0.61)	NMUR2NMUR1OPRM1OPRD1CALCR
SCHEMBL30233422	0.93	C5AR1 (0.58)	NMUR2NMUR1OPRM1OPRD1CXCR4
SCHEMBL30233254	0.92	OPRD1 (0.61)	NMUR2NMUR1OPRM1OPRD1CALCR
SCHEMBL30788363	0.91	NMUR2 (0.59)	NMUR2NMUR1OPRM1OPRD1EPHA2
SCHEMBL30788368	0.90	NMUR2 (0.58)	NMUR2NMUR1OPRM1OPRD1EPHA2
SCHEMBL30233475	0.90	OPRD1 (0.59)	NMUR2NMUR1OPRM1OPRD1CALCR
SCHEMBL29865041	0.90	OPRM1 (0.62)	NMUR2NMUR1OPRM1OPRD1EPHA2
SCHEMBL29864847	0.90	OPRM1 (0.62)	NMUR2NMUR1OPRM1OPRD1EPHA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-20240041740-A1	SKIN PEEL COMPOSITIONS	GLO PHARMA INC (US)	2024-02-08	—	—	US	disclosed